Elisabet Wieslander
Papers
1
Total Citations
13
H-Index
1
About
Elisabet Wieslander is a leading researcher in respiratory medicine, with a primary focus on the early detection and biomarker identification of chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Her seminal 2016 protocol paper, which has garnered 13 citations, outlines a groundbreaking longitudinal study designed to identify biomarkers of early COPD—a critical step toward diagnosing the disease before irreversible lung damage occurs. Wieslander’s work challenges the conventional understanding that only 15% of smokers develop COPD, demonstrating that most smokers experience some degree of pulmonary impairment. By establishing a framework for early biomarker discovery, her research has significant implications for preventive medicine and personalized treatment strategies. Her contributions are particularly notable for shifting the clinical paradigm from treating advanced COPD to intercepting the disease in its earliest, most reversible stages. Wieslander’s protocol has become a foundational reference for subsequent studies on smoking-related lung disease, underscoring her impact on the field. Her dedication to early diagnosis and biomarker research continues to influence respiratory health initiatives worldwide.
Research Focus
Key Achievements
Top Papers
- 1